New Results
CG14906 (mettl4) mediates m6A methylation of U2 snRNA in Drosophila
Lei Gu, Longfei Wang, Hao Chen, Jiaxu Hong, Zhangfei Shen, Abhinav Dhall, Taotao Lao, Chaozhong Liu, Zheng Wang, Yifan Xu, Hong-Wen Tang, Damayanti Chakraborty, Jiekai Chen, Zhihua Liu, Dragana Rogulja, Norbert Perrimon, Hao Wu, Yang Shi
doi: https://doi.org/10.1101/2020.01.09.890764
Lei Gu
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Longfei Wang
3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
4Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
Hao Chen
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Jiaxu Hong
5Department of Ophthalmology and Vision Science, Shanghai Eye, Ear, Nose and Throat Hospital, Fudan University, 200031 Shanghai, China
6Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, 550004 Guiyang, China
Zhangfei Shen
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Abhinav Dhall
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Taotao Lao
7Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Charlestown, MA 02129
Chaozhong Liu
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Zheng Wang
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Yifan Xu
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Hong-Wen Tang
8Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
Damayanti Chakraborty
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Jiekai Chen
9CAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, 510530 Guangzhou, China
Zhihua Liu
10Department of Neurobiology, Harvard Medical School, Boston, MA 02115
Dragana Rogulja
10Department of Neurobiology, Harvard Medical School, Boston, MA 02115
Norbert Perrimon
8Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
11Howard Hughes Medical Institute, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
Hao Wu
3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
4Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
Yang Shi
1Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Abstract
Recent studies reported that METTL4 regulates DNA 6mA in vivo and therefore is a candidate DNA m6A methyltransfease. However, the enzymatic activity of METTL4 in vitro has not been demonstrated in part due to the difficulties of obtaining well-folded proteins. Here we show that mettl4 is a major methyltransfase responsible for m6A methylation of U2 snRNA both in vitro and in vivo in fly, and identify adenosine at 29th position as the site of m6A methylation. This study answered a long-standing question regarding the enzymatic activity of METTL4, and thus paved the way for further investigating the functions of METTL4 in different biological settings.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Posted January 09, 2020.
CG14906 (mettl4) mediates m6A methylation of U2 snRNA in Drosophila
Lei Gu, Longfei Wang, Hao Chen, Jiaxu Hong, Zhangfei Shen, Abhinav Dhall, Taotao Lao, Chaozhong Liu, Zheng Wang, Yifan Xu, Hong-Wen Tang, Damayanti Chakraborty, Jiekai Chen, Zhihua Liu, Dragana Rogulja, Norbert Perrimon, Hao Wu, Yang Shi
bioRxiv 2020.01.09.890764; doi: https://doi.org/10.1101/2020.01.09.890764
CG14906 (mettl4) mediates m6A methylation of U2 snRNA in Drosophila
Lei Gu, Longfei Wang, Hao Chen, Jiaxu Hong, Zhangfei Shen, Abhinav Dhall, Taotao Lao, Chaozhong Liu, Zheng Wang, Yifan Xu, Hong-Wen Tang, Damayanti Chakraborty, Jiekai Chen, Zhihua Liu, Dragana Rogulja, Norbert Perrimon, Hao Wu, Yang Shi
bioRxiv 2020.01.09.890764; doi: https://doi.org/10.1101/2020.01.09.890764
Subject Area
Subject Areas
- Biochemistry (13697)
- Bioengineering (10429)
- Bioinformatics (33141)
- Biophysics (17097)
- Cancer Biology (14169)
- Cell Biology (20098)
- Clinical Trials (138)
- Developmental Biology (10866)
- Ecology (16008)
- Epidemiology (2067)
- Evolutionary Biology (20334)
- Genetics (13392)
- Genomics (18629)
- Immunology (13741)
- Microbiology (32149)
- Molecular Biology (13380)
- Neuroscience (70040)
- Paleontology (526)
- Pathology (2188)
- Pharmacology and Toxicology (3741)
- Physiology (5860)
- Plant Biology (12020)
- Synthetic Biology (3365)
- Systems Biology (8163)
- Zoology (1841)